{"id":"NCT00972777","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis","officialTitle":"A Study to Evaluate the Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% BID Compared to Vehicle in the Treatment of Bacterial Conjunctivitis.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2009-10","primaryCompletion":"2010-10","completion":"2011-02","firstPosted":"2009-09-09","resultsPosted":"2012-03-29","lastUpdate":"2012-03-29"},"enrollment":474,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bacterial Conjunctivitis"],"interventions":[{"type":"DRUG","name":"Besifloxacin","otherNames":["Besivance"]},{"type":"DRUG","name":"Vehicle (Placebo)","otherNames":[]}],"arms":[{"label":"Besifloxacin","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to evaluate the clinical and microbial efficacy of besifloxacin ophthalmic suspension compared with vehicle in the treatment of bacterial conjunctivitis. This study was conducted as a phase IIb study and continued with further enrollment as a phase III study.","primaryOutcome":{"measure":"Clinical Resolution","timeFrame":"Visit 2","effectByArm":[{"arm":"Besifloxacin","deltaMin":89,"sd":null},{"arm":"Vehicle","deltaMin":62,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22644963","22420526","21397770"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":228},"commonTop":[]}}